top of page

Compounding

Anchor 1

Custom Compounding

MEDICATIONS FOR YOUR FAMILY'S UNIQUE NEEDS.

Our pharmacists have been specially trained to prepare customized medications to meet every patient’s unique need - even your pet's! 

It is our aim to support and educate our patients and local physicians about the how compounded prescriptions can help. Our compounds can be created in a variety of forms for any number of reasons including:

  • To create a different or unique strength

  • To provide a different delivery form (i.e. liquid instead of pill)

  • To avoid an allergic medication reaction

  • To improve taste to ensure compliance

​

As a compounding pharmacy we strive to work with doctors, physicians and veterinarians to meet the health and safety standards. Our expertise varies and it is not limited to compounding medication such as:​

  • Adrenal Dysfunction/Thyroid Imbalance

  • Dentistry

  • Dermatology

  • Hormone Therapy for Men & Women

  • Pain Management

  • Palliative Care

  • Pediatrics

  • Podiatry

  • Sports Medicine

  • Unavailable Medications

  • Veterinary

  • Women's Health

  • Wound Care

  • And more!

It’s your body - why not give yourself the option of a customized,  individualized medication alternative. Ask your physician, or the Norland Avenue Pharmacy pharmacist, about compounding for any unique medication needs. If

About PCAB Accreditation

PCAB Accredited Compounding Pharmacy - a service of ACHC

Established in 2007 by eight of the nation’s leading pharmacy organizations, Pharmacy Compounding Accreditation Board (PCAB) offers the most comprehensive compliance solution in the industry, with standards based on U.S. Pharmacopeia Convention (USP) guidelines.

 

PCAB Accreditation means that our pharmacy:

  • Has been tested against an extremely challenging set of national standards and has met or exceeded all of them.

  • Uses only pure chemicals from FDA registered facilities.

  • Has an extensive quality assurance program and policies and procedures in place.

  • Meets strict continuous training guidelines to maintain  our employees’ skills while using a variety of advanced compounding equipment.

 

PCAB Accreditation confirms our commitment to providing safe, personalized solutions that meet the special needs of our patients and practitioners and demonstrates our dedication to being the best in our profession.

​

For more information on PCAB accreditation visit www.PCAB.org or call us at (717) 217-6790.

Not Local?
No Problem.

We are licensed to serve and ship to patients across Pennsylvania, Maryland, and West Virginia! 

 

If you're not local to us, we can still provide high-quality compounded medications! Give us a call to learn more about our prescription shipping options.  

Norland Avenue_Compounding_States.png

Low Dose Naltrexone (LDN)

EXPLORING THE USES OF LOW-DOSE NALTREXONE (LDN)

Naltrexone, an opiate receptor antagonist, is not a new drug, but when used off label at very low doses, is a drug shown in many trials to be of therapeutic benefit. The 50mg dose of Naltrexone was approved by the FDA in 1984 to treat opioid and alcohol addiction.

​

In 1985, Bernard Bihari, MD, a physician with a clinical practice in New York City, discovered the effects of a much smaller dose of Naltrexone. When reduced to doses ranging from 0.5mg to 9.0mg daily, it can modulate the immune system and may provide relief to those suffering from autoimmune diseases, chronic pain, mental health challenges, and inflammation.

Over the past ten years, there has been a growing body of evidence that the body’s endorphins (naturally occurring opioids) have a crucial role in regulating the immune system and providing pain relief. LDN’s blockade of opioid receptors has been shown to upregulate endorphin production. LDN’s blockade of Toll Like Receptors is believed to contribute to the anti-inflammatory and immune dampening effects.

​

These mechanisms help us understand why LDN can be beneficial for so many patients. LDN continues to provide life changing outcomes for many patients. It is available only by prescription and custom made at a compounding pharmacy.

​

The key to success in using LDN is an understanding that optimal dosing is ultimately patient specific and is not dependent on a set protocol. Dosing strategies can vary tremendously. Some patients find success very quickly, while others need to try a variety of dosing strategies, which may take up to several months to achieve success. Therefore, it is critical to work with a provider or a compounding pharmacy knowledgeable in strategies that can help ensure success with LDN.

​

Since we began specializing in LDN at Norland Avenue Pharmacy, we have seen a wide variety of successes. It is these successes that motivate us to continue to try to help other patients.

​

NOTE: Because LDN is an opioid receptor blocker, caution should be taken when prescribing LDN to patients who are taking opioid-type pain medications such as Morphine, Oxycodone, Hydrocodone, and Fentanyl.

Potential Clinical Uses & Trials for Low Dose Naltrexone:

  • ALS (Lou Gehrig's Disease)

  • Addiction

  • Addison's Disease

  • Alopecia Areata

  • Alzheimer's Disease

  • Amyotrophic Lateral Sclerosis

  • Ankylosing Spondylitis

  • Anxiety

  • Atopic Allergy

  • Atopic Dermatitis

  • Autism Spectrum Disorders

  • Behcet's Disease

  • Benign Prostatic Hypertrophy (BPH)

  • Brain Fog

  • COPD

  • CREST Syndrome

  • Celiac Disease

  • Chronic Fatigue Syndrome

  • Complex Regional Pain Syndrome

  • Crohn's Disease

  • Depression

  • Dermatomyositis

  • Diabetes Mellitus Type I

  • Eczema

  • Ehlers-Danlos Syndrome

  • Endometriosis

  • Fibromyalgia

  • General Anxiety Disorder

  • Granulomatosis

  • Graves’ Disease

  • HIV/AIDS

  • Hailey-Hailey Disease

  • Hashimoto’s Disease

  • Hypothyroidism

  • Irritable Bowel Syndrome (IBS)

  • Kawasaki’s Disease

  • Lupus

  • Lyme Disease

  • Meniere’s Disease

  • Migraine Headaches

  • Multiple Sclerosis (MS)

  • Obsessive Compulsive Disorder (OCD)

  • Pandas Disease

  • Parkinson’s Disease

  • Pemphigoid

  • Periodontal Disease

  • Polycystic Ovary Syndrome (PCOS)

  • Post-Traumatic Stress Disorder (PTSD)

  • Primary Lateral Sclerosis (PLS)

  • Psoriasis

  • Psoriatic Arthritis

  • Restless Leg Syndrome

  • Rheumatoid Arthritis

  • SIBO

  • Sarcoidosis

  • Scleroderma

  • Sjogren’s Syndrome

  • Stiff Person Syndrome (SPS)

  • Transverse Myelitis

  • Ulcerative Colitis

  • Wegener’s

  • Weight Loss

  • Women’s Health

  • Vitiligo

Patient Testimonials

"Before I felt bad all the time. I was sick a lot, and I didn't want to get out of bed. Now, I might have an occasional flare-up, but it's mostly under control." 

"I've done a complete 180. I recouped all my functions. It helps my sleep. My constitution is much stronger, and my immune system is much stronger."

"LDN is amazing! Before I started taking LDN my TSH level was 4.5. After three months on LDN, my TSH level was 0.8."

…for Multiple Sclerosis

Cree et al: Naltrexone and QOL in MS Annals of Neurology. February 2010(1)1-18 | UC-San Francisco Medical School https://www.ncbi.nlm.nih.gov/pubmed/20695007

…for Depression

Mischoulon et al: For Patients with Breakthrough Depression of Major Depressive Disorder (MDD) on Antidepressants. Journal of Affective Disorders 208. (2017) 6-14 | Harvard Medical School https://www.jaacap.org/article/S0165-0327(16)30449-9/abstract

…for Fibromyalgia

Younger et al: Fibromyalgia Symptoms are Reduced by Low-Dose Naltrexone: A Pilot Study. Pain Medicine 2009 (10):663-72 | Stanford Medical School https://www.ncbi.nlm.nih.gov/pubmed/19453963

…for Crohn’s Disease

Smith et al: Low-Dose Naltrexone Therapy Improves Active Crohn’s Disease Pilot Study. Am J Gastroenterol 2007; 102:820-828 | Penn State Medical School https://www.ncbi.nlm.nih.gov/pubmed/17222320

…for Inflammation and Pain

Younger et al: The Use of Low-Dose Naltrexone (LDN) as a Novel Anti-Inflammatory Treatment for Chronic Pain. Clinical Rheumatology (2014) 33:451-459 | Stanford Medical School https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962576/

Refer to LDNresearchtrust.org for more information

bottom of page